Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) within Human RGS18 aa 1-100. The exact sequence is proprietary.Database link: Q9NS28
Conjugate
Unconjugated
Applications
Application Notes
WB: 1/1000 - 1/2000;
Target
Alternative Names
RGS18; regulator of G-protein signaling 18; regulator of G protein signalling 18; RGS13; regulator of G-protein signalling 13; regulator of G-protein signalling 18;
Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Binds to G(i) alpha-1, G(i) alpha-2, G(i) alpha-3 and G(q) alpha.
Pathway
Calcium Regulation in the Cardiac Cell, organism-specific biosystem; G alpha (i) signalling events, organism-specific biosystem; G alpha (q) signalling events, organism-specific biosystem; GPCR downstream signaling, organism-specific biosystem; Myometrial Relaxation and Contraction Pathways, organism-specific biosystem; Signal Transduction, organism-specific biosystem; Signaling by GPCR, organism-specific biosystem;
Citations
Publication ()
Have you cited DCABH-7352 in a publication? Let us know and earn a reward for your research.
Q: Would you be able to share the buffer formulation for Anti-RGS18 monoclonal antibody, clone FQS24516 with me?
A: Yes, the buffer formulation for Anti-RGS18 monoclonal antibody, clone FQS24516 is supplied in Preservative: 0.01% Sodium azide; Constituents: 59% PBS, 40% Glycerol, 0.05% BSA.
Customer Reviews
My Review for Anti-RGS18 monoclonal antibody, clone FQS24516
Creative Diagnostics products are for RESEARCH USE ONLY, please make sure your review is research based.
Required fields are marked with *
Terms and conditions:
We will select high-quality review customers and offer a $30 coupon for your next purchase.
All product reviews must be submitted in the English language.
Creative Diagnostics will not share any personal information of applicants, and all information will be treated with strict confidentiality and will not be sold or disclosed to a third party.
COA
Publication 
Loading ......
